Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications
- Author
- Evi Debruyne (UGent) and Joris Delanghe (UGent)
- Organization
- Abstract
- Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage. Serum alpha-fetoprotein (AFP) is one of the most common diagnostic markers for hepatocellular carcinoma. However. its diagnostic value is more and more questioned. Therefore, research has focussed on AFP related parameters (AFP mRNA and AFP glycoforms). The aim of this paper is to review the present knowledge on AFP and its related parameters in diagnosing and monitoring HCC. AFP related parameters can be arranged in two types: AFP mRNA and AFP glycoforms. AFP mRNA is a potentially prognostic marker and AFP mRNA assays are based on PCR techniques. The AFP glycoforms have diagnostic potential and assays are based on isoelectric focussing and lectin affinity electrophoretic methods. Up to now the diagnostic use of the AFP related parameters is limited. Although some of them are recommended as a complementary test, they cannot (yet) replace serum AFP as the golden standard of diagnostic markers for hepatocellular carcinoma. (C) 2008 Elsevier B.V. All rights reserved.
- Keywords
- AFP, CIRRHOTIC-PATIENTS, glycoforms, hepatocellular carcinoma, tumour marker, LECTIN AFFINITY ELECTROPHORESIS, GAMMA-CARBOXY PROTHROMBIN, CIRCULATING TUMOR-CELLS, CHRONIC LIVER-DISEASE, POLYMERASE-CHAIN-REACTION, MESSENGER-RNA, PERIPHERAL VENOUS-BLOOD, FUCOSYLATION INDEX, MOLECULAR VARIANTS
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 245.04 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-524265
- MLA
- Debruyne, Evi, and Joris Delanghe. “Diagnosing and Monitoring Hepatocellular Carcinoma with Alpha-Fetoprotein: New Aspects and Applications.” CLINICA CHIMICA ACTA, vol. 395, no. 1–2, Elsevier Science, 2008, pp. 19–26, doi:10.1016/j.cca.2008.05.010.
- APA
- Debruyne, E., & Delanghe, J. (2008). Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications. CLINICA CHIMICA ACTA, 395(1–2), 19–26. https://doi.org/10.1016/j.cca.2008.05.010
- Chicago author-date
- Debruyne, Evi, and Joris Delanghe. 2008. “Diagnosing and Monitoring Hepatocellular Carcinoma with Alpha-Fetoprotein: New Aspects and Applications.” CLINICA CHIMICA ACTA 395 (1–2): 19–26. https://doi.org/10.1016/j.cca.2008.05.010.
- Chicago author-date (all authors)
- Debruyne, Evi, and Joris Delanghe. 2008. “Diagnosing and Monitoring Hepatocellular Carcinoma with Alpha-Fetoprotein: New Aspects and Applications.” CLINICA CHIMICA ACTA 395 (1–2): 19–26. doi:10.1016/j.cca.2008.05.010.
- Vancouver
- 1.Debruyne E, Delanghe J. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications. CLINICA CHIMICA ACTA. 2008;395(1–2):19–26.
- IEEE
- [1]E. Debruyne and J. Delanghe, “Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications,” CLINICA CHIMICA ACTA, vol. 395, no. 1–2, pp. 19–26, 2008.
@article{524265, abstract = {{Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage. Serum alpha-fetoprotein (AFP) is one of the most common diagnostic markers for hepatocellular carcinoma. However. its diagnostic value is more and more questioned. Therefore, research has focussed on AFP related parameters (AFP mRNA and AFP glycoforms). The aim of this paper is to review the present knowledge on AFP and its related parameters in diagnosing and monitoring HCC. AFP related parameters can be arranged in two types: AFP mRNA and AFP glycoforms. AFP mRNA is a potentially prognostic marker and AFP mRNA assays are based on PCR techniques. The AFP glycoforms have diagnostic potential and assays are based on isoelectric focussing and lectin affinity electrophoretic methods. Up to now the diagnostic use of the AFP related parameters is limited. Although some of them are recommended as a complementary test, they cannot (yet) replace serum AFP as the golden standard of diagnostic markers for hepatocellular carcinoma. (C) 2008 Elsevier B.V. All rights reserved.}}, author = {{Debruyne, Evi and Delanghe, Joris}}, issn = {{0009-8981}}, journal = {{CLINICA CHIMICA ACTA}}, keywords = {{AFP,CIRRHOTIC-PATIENTS,glycoforms,hepatocellular carcinoma,tumour marker,LECTIN AFFINITY ELECTROPHORESIS,GAMMA-CARBOXY PROTHROMBIN,CIRCULATING TUMOR-CELLS,CHRONIC LIVER-DISEASE,POLYMERASE-CHAIN-REACTION,MESSENGER-RNA,PERIPHERAL VENOUS-BLOOD,FUCOSYLATION INDEX,MOLECULAR VARIANTS}}, language = {{eng}}, number = {{1-2}}, pages = {{19--26}}, publisher = {{Elsevier Science}}, title = {{Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications}}, url = {{http://doi.org/10.1016/j.cca.2008.05.010}}, volume = {{395}}, year = {{2008}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: